Clinical Trial Update: Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial [Phase 3]

View source ↗

Summary

This clinical trial update describes two Phase 3 studies within the PREDICT-RT trial for high-risk prostate cancer, testing reduced-intensity treatment for pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: NRG Oncology | Conditions: Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 | Phase 3 | Status: ACTIVE_NOT_RECRUITING